Skip to main content
TipRanks
Go Ultimate75% OFF

Redcare Pharmacy (0RJT) Share Price & Analysis

11 Followers

0RJT Stock Chart & Stats

€68.05-€1.00(-1.45%)
At close: 4:30 PM GMT
€50€60€70€80Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
EUR 67.00 - EUR 69.15
52-Week Range
EUR 30.20 - EUR 79.55
Previous Close
EUR 69.05
Volume
N/A
Average Volume (3M)
3,466
Market Cap
EUR 1.40B
Enterprise Value
EUR 1.72B
Total Cash (Recent Filing)
EUR 132.40M
Total Debt (Recent Filing)
EUR 354.50M
Price to Earnings (P/E)
―
Beta
1.27
Next Earnings
Mar 03, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth

Sustained revenue expansion shows that Redcare is increasing its commercial scale across online pharmacy and health products. A larger sales base can improve purchasing leverage, spread fixed logistics costs, and support continued investment in customer acquisition and fulfillment capacity.

Improving Losses And Operating Cash Flow

Positive operating cash flow and narrower losses indicate that the business is moving toward better operating economics, even though it is not yet profitable. Continued improvement could reduce reliance on external funding and provide more flexibility to support growth initiatives.

Stable Capital Base

A substantial and broadly stable equity base provides Redcare with financial capacity relative to its asset scale. Historically manageable leverage can support ongoing investment in its platform and distribution operations, although the reported debt figures remain a factor to monitor.

Bears Say

Persistent Net Losses

Redcare remains loss-making despite its large revenue base, while operating profit is modest relative to sales. Persistent negative earnings constrain internally funded growth, weaken returns on shareholder capital, and leave the company more exposed if progress toward profitability stalls.

Gross Margin Compression

The sustained decline in gross margin reduces the amount of revenue available to cover fulfillment, marketing, technology, and corporate costs. Unless the business improves product mix or operating efficiency, margin compression will limit earnings leverage even as sales continue to grow.

Negative Free Cash Flow

Negative free cash flow means operating cash generation is not currently sufficient after reinvestment and working-capital demands. If this pattern persists, Redcare may need additional financing to sustain expansion, reducing financial flexibility and increasing dependence on capital markets.

Redcare Pharmacy News

0RJT FAQ

What was Redcare Pharmacy’s price range in the past 12 months?
Redcare Pharmacy lowest share price was €30.20 and its highest was €79.55 in the past 12 months.
What is Redcare Pharmacy’s market cap?
Redcare Pharmacy’s market cap is €1.40B.
When is Redcare Pharmacy’s upcoming earnings report date?
Redcare Pharmacy’s next earnings report is estimated for Mar 03, 2027 (not yet confirmed), which is in 106 days.
How were Redcare Pharmacy’s earnings last quarter?
Redcare Pharmacy released its earnings results on Oct 29, 2026. The company reported -€0.01 earnings per share for the quarter, missing the consensus estimate of €0.066 by -€0.076.
Is Redcare Pharmacy overvalued?
According to Wall Street analysts Redcare Pharmacy’s price is currently Undervalued.
Does Redcare Pharmacy pay dividends?
Redcare Pharmacy does not currently pay dividends.
What is Redcare Pharmacy’s EPS estimate?
Redcare Pharmacy’s EPS estimate is -0.26.
How many shares outstanding does Redcare Pharmacy have?
Redcare Pharmacy has 20,578,390 shares outstanding.
What happened to Redcare Pharmacy’s price movement after its last earnings report?
Redcare Pharmacy reported an EPS of -€0.01 in its last earnings report, missing expectations of €0.066. Following the earnings report the stock price went down -5.422%.
Which hedge fund is a major shareholder of Redcare Pharmacy?
Currently, no hedge funds are holding shares in GB:0RJT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology